← Eichor
Study identifier: NCT06467019 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Informative Exhibition for Deprescribing Benzodiazepines

Condition: Benzodiazepine-Related Disorders  ·  Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf

PhaseN/A
Planned participants6410
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is: • Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center. Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.

This description comes directly from the study's public registry record.

Talk to the study team

Jordi Milozzi, MD  ·  +34 938 10 30 03  ·  jmilozzi@csapg.cat

Noemí Casaponsa  ·  +34 938960025  ·  recerca@csapg.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Centro de Salud Vilanova i la Geltrú 3 Baix A MarVilanova i la Geltrú, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06467019